Dysphagia Therapy for Alzheimer's Disease
Trial Summary
What is the purpose of this trial?
This trial tests a saliva gel and tongue exercises to help people with Alzheimer's who have trouble swallowing. These patients are at risk of pneumonia because they can't swallow well. The saliva gel keeps their mouth moist, and the exercises make their tongue stronger to help with swallowing.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of this treatment for dysphagia in Alzheimer's patients?
Is tongue strengthening exercise safe for humans?
Research shows that tongue strengthening exercises, often using devices like the Iowa Oral Performance Instrument (IOPI), are generally safe for humans, including healthy adults and those with medical conditions. These exercises have been studied in various groups, and no significant safety concerns have been reported.34567
How is the isometric tongue strengthening treatment for dysphagia in Alzheimer's patients unique?
The isometric tongue strengthening treatment using the Iowa Oral Performance Instrument (IOPI) is unique because it focuses on improving tongue strength and accuracy through resistance training, which is not typically emphasized in other dysphagia treatments for Alzheimer's disease. This approach uses biofeedback to help patients achieve specific pressure targets, potentially enhancing swallowing function.248910
Research Team
Nicole Rogus-Pulia, PhD, CCC-SLP
Principal Investigator
University of Wisconsin, Madison
Eligibility Criteria
This trial is for English-speaking patients aged 50-99 with dementia or memory loss, scoring 0.5-2.0 on the CDR scale, living at home or in assisted living. Caregivers must be over 18, speak English, have weekly contact with the patient and a working phone. Excluded are those with certain cerebrovascular diseases, head/neck cancer history, barium allergies, or pregnancy.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Baseline assessment including sociodemographics, comorbidities, medications, cognitive assessment, and oral health status
Treatment
Participants undergo interventions including lingual strengthening and/or saliva substitute use for 8 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment, including changes in salivary production, pneumonia diagnoses, and swallowing quality of life
Treatment Details
Interventions
- Biotene Oral Balance Gel (Behavioural Intervention)
- Isometric tongue strengthening facilitated by Iowa Oral Performance Instrument (IOPI) (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Wisconsin, Madison
Lead Sponsor
Robert Drape
University of Wisconsin, Madison
Chief Executive Officer since 2007
Executive MBA from the University of Wisconsin – Madison, Bachelor's degree in Biology from Augustana College (IL)
Dr. Ciara Barclay-Buchanan
University of Wisconsin, Madison
Chief Medical Officer since 2023
MD from Wayne State University School of Medicine
National Institute on Aging (NIA)
Collaborator
Dr. Richard J. Hodes
National Institute on Aging (NIA)
Chief Executive Officer since 1993
MD from Harvard Medical School
Dr. Marie Bernard
National Institute on Aging (NIA)
Chief Medical Officer
MD from Harvard Medical School